In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pemigatinibis mainly used to treat specific diseases such as advanced or metasta···【more】
Release date:2024-08-13Recommended:503
Pemigatinib is used in adults to treat bile duct cancer that has spread to other···【more】
Release date:2024-08-13Recommended:474
Pemigatinib is a targeted therapy drug developed by Incyte in the United States,···【more】
Release date:2024-08-12Recommended:443
Venetoclax is a drug used to treat leukemias, specifically chronic lymphocytic l···【more】
Release date:2024-08-09Recommended:538
Venetoclax is a BCL-2 inhibitor that selectively binds to BCL-2 protein and inhi···【more】
Release date:2024-08-09Recommended:491
Pemigatinib is a potent and selective oral antineoplastic drug targeting the FGF···【more】
Release date:2024-08-09Recommended:487
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed i···【more】
Release date:2024-08-09Recommended:388
Venetoclax is a drug used to treat chronic lymphocytic leukemia (CLL) and certai···【more】
Release date:2024-08-09Recommended:524
Capmatinib is a targeted drug manufactured by Novartis for the treatment of pati···【more】
Release date:2024-08-09Recommended:548
Capmatinib, trade name Tabrecta. It is an oral MET inhibitor mainly used for the···【more】
Release date:2024-08-09Recommended:533
Capmatinib is an oral, selective, ATP-competitive c-Met kinase inhibitor that in···【more】
Release date:2024-08-09Recommended:549
Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.H···【more】
Release date:2024-08-09Recommended:483